ArticleFrontiers in pharmacology2022

Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials.

Andrés López-Cortés et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.